Congressional Panel to Probe Generic Drug Price Hikes
WASHINGTON, Nov. 11 – Sen. Bernie Sanders (I-Vt.) announced today that a Senate panel he chairs will hold a hearing next week to explore why the costs of certain generic drugs are skyrocketing. Rep. Elijah Cummings (D-Md.), who has worked with Sanders on this issue, will take part in the Nov. 20 hearing of the Senate Subcommittee on Primary Health and Aging.
Price hikes for generic drugs also reportedly have come under scrutiny by the U.S. Department of Justice. Subpoenas recently were issued to two generic drug makers seeking information about their interactions with competitors, The Wall Street Journal disclosed on Monday.